PT3235494T - Preparação transdérmica contendo donepezilo como ingrediente ativo - Google Patents

Preparação transdérmica contendo donepezilo como ingrediente ativo

Info

Publication number
PT3235494T
PT3235494T PT158703652T PT15870365T PT3235494T PT 3235494 T PT3235494 T PT 3235494T PT 158703652 T PT158703652 T PT 158703652T PT 15870365 T PT15870365 T PT 15870365T PT 3235494 T PT3235494 T PT 3235494T
Authority
PT
Portugal
Prior art keywords
active ingredient
preparation containing
transdermal preparation
containing donepezil
donepezil
Prior art date
Application number
PT158703652T
Other languages
English (en)
Original Assignee
Icure Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Icure Pharm Inc filed Critical Icure Pharm Inc
Publication of PT3235494T publication Critical patent/PT3235494T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT158703652T 2014-12-18 2015-12-18 Preparação transdérmica contendo donepezilo como ingrediente ativo PT3235494T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR20140183446 2014-12-18

Publications (1)

Publication Number Publication Date
PT3235494T true PT3235494T (pt) 2020-03-05

Family

ID=56126987

Family Applications (1)

Application Number Title Priority Date Filing Date
PT158703652T PT3235494T (pt) 2014-12-18 2015-12-18 Preparação transdérmica contendo donepezilo como ingrediente ativo

Country Status (15)

Country Link
US (1) US10888533B2 (pt)
EP (1) EP3235494B1 (pt)
JP (1) JP6793648B2 (pt)
KR (1) KR101796771B1 (pt)
CN (2) CN113797180A (pt)
AU (1) AU2015363883B2 (pt)
CA (1) CA2970276C (pt)
DK (1) DK3235494T3 (pt)
ES (1) ES2786399T3 (pt)
HU (1) HUE048569T2 (pt)
MY (1) MY181540A (pt)
PL (1) PL3235494T3 (pt)
PT (1) PT3235494T (pt)
RU (1) RU2713207C2 (pt)
WO (1) WO2016099198A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10835499B2 (en) 2015-12-30 2020-11-17 Corium, Inc. Systems and methods for long term transdermal administration
WO2017223402A1 (en) 2016-06-23 2017-12-28 Corium International, Inc. Adhesive matrix with hydrophilic and hydrophobic domains and a therapeutic agent
CA3031944A1 (en) 2016-07-27 2018-02-01 Corium International, Inc. Transdermal delivery systems with pharmacokinetics bioequivalent to oral delivery
RU2764764C2 (ru) 2016-07-27 2022-01-21 Кориум Интернэшнл, Инк. Трансдермальные системы доставки мемантина
CN109789105B (zh) 2016-07-27 2022-12-27 考里安公司 通过盐至中性药物原位转化的组合物、透皮贴剂及应用
KR102033686B1 (ko) * 2017-05-19 2019-10-18 보령제약 주식회사 도네페질을 함유하는 마이크로니들 경피 패치
KR20200032153A (ko) * 2017-07-26 2020-03-25 코리움, 인크. 용매가 채워진 공극을 가진 미세다공성 막을 구비한 경피 전달 시스템
CA3086163A1 (en) 2017-12-20 2019-06-27 Corium, Inc. Transdermal adhesive composition comprising a volatile liquid therapeutic agent having low melting point
KR102024996B1 (ko) * 2017-12-27 2019-09-25 동아에스티 주식회사 도네페질을 함유하는 치매 치료용 경피흡수제제
KR102115102B1 (ko) * 2018-12-21 2020-05-26 동아에스티 주식회사 안정화된 도네페질 함유 경피 흡수제제
KR20230056268A (ko) 2021-10-20 2023-04-27 서울대학교병원 치매 약물의 부작용을 평가할 수 있는 치매 약물 패치

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985317A (en) * 1996-09-06 1999-11-16 Theratech, Inc. Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents
JP3987655B2 (ja) 1998-03-03 2007-10-10 エーザイ・アール・アンド・ディー・マネジメント株式会社 抗痴呆薬を含有した経皮適用製剤又は坐剤
WO2002069942A1 (fr) * 2001-03-07 2002-09-12 Hisamitsu Pharmaceutical Co., Inc. Timbre adhesif
JP4394443B2 (ja) 2001-10-17 2010-01-06 久光製薬株式会社 経皮吸収型製剤
CA2671006A1 (en) * 2006-12-01 2008-06-05 Nitto Denko Corporation Method for suppressing discoloration over time of adhesive preparation containing donepezil
KR101454362B1 (ko) * 2008-03-24 2014-10-23 아이큐어 주식회사 도네페질을 유효성분으로 함유하는 치매 치료용경피흡수제제
US20090291127A1 (en) 2008-05-21 2009-11-26 Jianye Wen Transdermal anti-dementia active agent formulations and methods for using the same
JP2012504163A (ja) * 2008-09-30 2012-02-16 テイコク ファーマ ユーエスエー インコーポレーテッド 経皮持続送達ドネペジル組成物および該組成物を使用する方法
US8456368B2 (en) * 2009-01-27 2013-06-04 Casio Computer Co., Ltd. Antenna device and radio-wave receiver with such antenna device
US20100209484A1 (en) * 2009-02-13 2010-08-19 Hoo-Kyun Choi Transdermal Triptan Delivery System
KR101325104B1 (ko) * 2009-09-16 2013-11-07 주식회사 삼양바이오팜 경피 투여 제형 및 그 제조 방법
JP2012236773A (ja) * 2009-12-16 2012-12-06 Goto Takeshi 抗認知症薬物の経皮吸収製剤
US20100178307A1 (en) * 2010-01-13 2010-07-15 Jianye Wen Transdermal anti-dementia active agent formulations and methods for using the same
NZ605352A (en) * 2010-06-30 2013-10-25 Nal Pharmaceuticals Ltd Process for producing glycosaminoglycans
TWI433904B (zh) * 2011-01-12 2014-04-11 Taiwan Biotech Co Ltd 多奈哌齊經皮貼片
KR101395557B1 (ko) * 2011-08-25 2014-05-16 아이큐어 주식회사 경피 흡수 제제 및 그 제조방법
KR101239150B1 (ko) * 2012-02-28 2013-03-06 에스케이케미칼주식회사 도네페질-함유 경피흡수제제 및 그의 제조방법
US9539201B2 (en) * 2012-04-20 2017-01-10 KAT Transdermals LLC Selegiline transdermal system
CN102895217A (zh) * 2012-11-13 2013-01-30 沈阳药科大学 长效多奈哌齐经皮吸收贴剂
KR101770675B1 (ko) * 2013-01-30 2017-08-23 에스케이케미칼주식회사 도네페질-함유 경피흡수제제 및 그의 제조방법
CN108123793A (zh) * 2017-12-19 2018-06-05 杭州中天微***有限公司 基于apb总线的spi通信装置

Also Published As

Publication number Publication date
ES2786399T3 (es) 2020-10-09
EP3235494A1 (en) 2017-10-25
EP3235494A4 (en) 2018-08-15
PL3235494T3 (pl) 2020-08-24
CN113797180A (zh) 2021-12-17
EP3235494B1 (en) 2019-11-27
CA2970276C (en) 2023-08-01
US10888533B2 (en) 2021-01-12
DK3235494T3 (da) 2020-03-02
KR101796771B1 (ko) 2017-11-10
US20170290780A1 (en) 2017-10-12
CN107106510A (zh) 2017-08-29
CA2970276A1 (en) 2016-06-23
RU2713207C2 (ru) 2020-02-04
KR20160074433A (ko) 2016-06-28
BR112017012951A2 (pt) 2018-03-06
JP6793648B2 (ja) 2020-12-02
RU2017125361A3 (pt) 2019-07-17
RU2017125361A (ru) 2019-01-18
AU2015363883B2 (en) 2021-03-25
WO2016099198A1 (ko) 2016-06-23
HUE048569T2 (hu) 2020-07-28
JP2017538771A (ja) 2017-12-28
AU2015363883A1 (en) 2017-06-29
MY181540A (en) 2020-12-28

Similar Documents

Publication Publication Date Title
HK1245625A1 (zh) 用於經皮施用的方法和製劑
IL252550A0 (en) Cannabinoid compounds through the skin
PL3235494T3 (pl) Preparat transdermalny zawierający donepezil jako składnik aktywny
IL248984A0 (en) Transdermal cream
IL247427A0 (en) A chemical agricultural preparation for the treatment of plants
IL252062A0 (en) Transdermal compositions
GB201516729D0 (en) Liquid nicotine formulation
EP3096745A4 (en) Transdermal delivery system comprising donepezil or its salt
SG11201702298VA (en) Pharmaceutical preparation
IL251059B (en) Arimoclomol formulation
IL273087A (en) Transdermal compositions
HK1243927A1 (zh) 含有茶皂醇衍生物作爲活性成分的組合物
SG11201610636VA (en) Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor
IL249010A0 (en) A pharmaceutical preparation containing a pyrazine carboxamide compound as an active ingredient
SG11201608845PA (en) Cosmetic composition containing mentha haplocalyx as active ingredient
PL3184492T3 (pl) Preparat antyseptyczny
EP3107532A4 (en) Transdermal drug delivery system containing donepezil
EP3100721A4 (en) Capsule formulation
EP3181125A4 (en) Capsule formulation
IL258295A (en) Fviii formulation
EP3150205A4 (en) Transdermal preparation
ZA201500995B (en) Low dose pharmaceutical composition
GB201417589D0 (en) Pharmaceutical Formulations
IL258675A (en) Mosquito repellent compounds
EP3299012A4 (en) Transdermal liquid preparation